Protein | Potency Measurements | Inhibition Measurements | Activation Measurements | Drugs |
Chain B, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, pheromone binding protein | 0 | 0 | 1 | 1 |
Chain A, JmjC domain-containing histone demethylation protein 3A | 11 | 0 | 0 | 11 |
Chain A, RNA-directed RNA polymerase NS5 | 0 | 2 | 0 | 2 |
acid sphingomyelinase | 3 | 0 | 0 | 3 |
thioredoxin reductase | 22 | 0 | 0 | 22 |
USP1 protein, partial | 19 | 0 | 0 | 19 |
TDP1 protein | 46 | 0 | 0 | 46 |
vitamin D3 receptor isoform VDRA | 16 | 0 | 0 | 16 |
importin subunit beta-1 isoform 1 | 5 | 0 | 0 | 5 |
flap endonuclease 1 | 19 | 0 | 0 | 19 |
serine/threonine-protein kinase PLK1 | 3 | 0 | 0 | 3 |
snurportin-1 | 5 | 0 | 0 | 5 |
peptidyl-prolyl cis-trans isomerase NIMA-interacting 1 | 7 | 0 | 0 | 7 |
GTP-binding nuclear protein Ran isoform 1 | 4 | 0 | 0 | 4 |
DNA polymerase eta isoform 1 | 4 | 0 | 0 | 4 |
DNA polymerase iota isoform a (long) | 19 | 0 | 0 | 19 |
urokinase-type plasminogen activator precursor | 10 | 0 | 0 | 10 |
plasminogen precursor | 10 | 0 | 0 | 10 |
urokinase plasminogen activator surface receptor precursor | 10 | 0 | 0 | 10 |
geminin | 45 | 0 | 0 | 45 |
DNA polymerase kappa isoform 1 | 13 | 0 | 0 | 13 |
fibroblast growth factor 22 isoform 1 precursor | 0 | 0 | 0 | 1 |
Mitogen-activated protein kinase 13 | 0 | 1 | 0 | 1 |
Beta-lactamase | 0 | 2 | 0 | 2 |
Transthyretin | 0 | 1 | 2 | 3 |
Fatty acid-binding protein, intestinal | 0 | 2 | 1 | 3 |
Fatty acid-binding protein, adipocyte | 0 | 1 | 1 | 2 |
Cyclin-A2 | 0 | 1 | 0 | 1 |
Cannabinoid receptor 1 | 0 | 0 | 1 | 1 |
Cyclin-dependent kinase 2 | 0 | 1 | 1 | 2 |
Choline O-acetyltransferase | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 12 | 0 | 1 | 0 | 1 |
Guanine nucleotide-binding protein G | 10 | 0 | 0 | 10 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Fatty acid-binding protein 5 | 0 | 0 | 1 | 1 |
Mitogen-activated protein kinase 11 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 14 | 0 | 5 | 0 | 5 |
GLI family zinc finger 3 | 44 | 0 | 0 | 44 |
AR protein | 64 | 0 | 0 | 64 |
aldehyde dehydrogenase 1 family, member A1 | 27 | 0 | 0 | 27 |
retinoic acid nuclear receptor alpha variant 1 | 49 | 0 | 0 | 49 |
Luciferase | 26 | 0 | 0 | 26 |
RAR-related orphan receptor gamma | 44 | 0 | 0 | 44 |
estrogen receptor 2 (ER beta) | 28 | 0 | 0 | 28 |
nuclear receptor subfamily 1, group I, member 3 | 35 | 0 | 0 | 35 |
progesterone receptor | 34 | 0 | 0 | 34 |
retinoid X nuclear receptor alpha | 40 | 0 | 0 | 40 |
pregnane X nuclear receptor | 44 | 0 | 0 | 44 |
estrogen nuclear receptor alpha | 60 | 0 | 0 | 60 |
peroxisome proliferator-activated receptor delta | 30 | 0 | 0 | 30 |
aryl hydrocarbon receptor | 29 | 0 | 0 | 29 |
cytochrome P450, family 19, subfamily A, polypeptide 1, isoform CRA_a | 38 | 0 | 0 | 38 |
v-jun sarcoma virus 17 oncogene homolog (avian) | 26 | 0 | 0 | 26 |
Histone H2A.x | 21 | 0 | 0 | 21 |
thyroid hormone receptor beta isoform 2 | 37 | 0 | 0 | 37 |
nuclear factor erythroid 2-related factor 2 isoform 1 | 44 | 0 | 0 | 44 |
DNA repair and recombination protein RadA | 0 | 0 | 1 | 1 |
Voltage-dependent calcium channel gamma-2 subunit | 31 | 0 | 0 | 31 |
Cellular tumor antigen p53 | 41 | 0 | 0 | 41 |
Cytochrome P450 1A2 | 0 | 6 | 0 | 6 |
Cytochrome P450 2A6 | 0 | 3 | 0 | 3 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Glutamate receptor 2 | 31 | 0 | 0 | 31 |
Cytochrome P450 2A5 | 0 | 1 | 0 | 1 |
Sulfotransferase 1E1 | 0 | 0 | 0 | 1 |
Sulfotransferase 1A1 | 0 | 0 | 0 | 1 |
Sulfotransferase 2A1 | 0 | 0 | 0 | 1 |
hypoxia-inducible factor 1 alpha subunit | 17 | 0 | 0 | 17 |
activating transcription factor 6 | 17 | 0 | 0 | 17 |
thyroid hormone receptor beta isoform a | 20 | 0 | 0 | 20 |
heat shock protein beta-1 | 22 | 0 | 0 | 22 |
lamin isoform A-delta10 | 35 | 0 | 0 | 35 |
Protein skinhead-1 | 0 | 1 | 0 | 1 |
Monocarboxylate transporter 2 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 20 | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 3 |
Calmodulin-domain protein kinase 1 | 0 | 2 | 0 | 2 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain A, Avidin | 0 | 0 | 1 | 1 |
Chain B, Avidin | 0 | 0 | 1 | 1 |
Chain A, Ferritin light chain | 13 | 0 | 0 | 13 |
Microtubule-associated protein tau | 18 | 0 | 0 | 18 |
Smad3 | 9 | 0 | 0 | 9 |
alpha-galactosidase | 5 | 0 | 0 | 5 |
15-hydroxyprostaglandin dehydrogenase [NAD(+)] isoform 1 | 12 | 0 | 0 | 12 |
DNA topoisomerase 2-alpha | 0 | 0 | 0 | 2 |
Acetylcholinesterase | 0 | 6 | 0 | 6 |
Chain A, MAJOR APURINIC/APYRIMIDINIC ENDONUCLEASE | 23 | 0 | 0 | 23 |
Chain A, TYROSYL-DNA PHOSPHODIESTERASE | 18 | 0 | 0 | 18 |
Carbonic anhydrase 1 | 0 | 10 | 0 | 14 |
Carbonic anhydrase 2 | 0 | 10 | 1 | 16 |
Alanine racemase, biosynthetic | 0 | 0 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 0 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 2 | 0 | 3 |
Proton-coupled amino acid transporter 1 | 0 | 2 | 0 | 2 |
Adenosine deaminase | 0 | 0 | 0 | 1 |
Carbonic anhydrase 4 | 0 | 1 | 0 | 3 |
Chain A, Beta-lactamase | 13 | 0 | 0 | 13 |
glp-1 receptor, partial | 16 | 0 | 0 | 16 |
ATAD5 protein, partial | 17 | 0 | 0 | 17 |
Fumarate hydratase | 14 | 0 | 0 | 14 |
caspase 7, apoptosis-related cysteine protease | 13 | 0 | 0 | 13 |
glucocorticoid receptor [Homo sapiens] | 40 | 0 | 0 | 40 |
estrogen-related nuclear receptor alpha | 53 | 0 | 0 | 53 |
farnesoid X nuclear receptor | 29 | 0 | 0 | 29 |
polyprotein | 14 | 0 | 0 | 14 |
67.9K protein | 12 | 0 | 0 | 12 |
peroxisome proliferator activated receptor gamma | 31 | 0 | 0 | 31 |
vitamin D (1,25- dihydroxyvitamin D3) receptor | 30 | 0 | 0 | 30 |
caspase-3 | 13 | 0 | 0 | 13 |
IDH1 | 20 | 0 | 0 | 20 |
euchromatic histone-lysine N-methyltransferase 2 | 36 | 0 | 0 | 36 |
nuclear receptor subfamily 1, group I, member 2 | 10 | 0 | 0 | 10 |
cellular tumor antigen p53 isoform a | 14 | 0 | 0 | 14 |
chromobox protein homolog 1 | 23 | 0 | 0 | 23 |
nuclear factor erythroid 2-related factor 2 isoform 2 | 16 | 0 | 0 | 16 |
transcriptional regulator ERG isoform 3 | 9 | 0 | 0 | 9 |
histone deacetylase 9 isoform 3 | 13 | 0 | 0 | 13 |
mitogen-activated protein kinase 1 | 18 | 0 | 0 | 18 |
Vif | 0 | 1 | 0 | 2 |
peripheral myelin protein 22 | 25 | 0 | 0 | 25 |
survival motor neuron protein isoform d | 19 | 0 | 0 | 19 |
muscleblind-like protein 1 isoform 1 | 10 | 0 | 0 | 10 |
DNA dC->dU-editing enzyme APOBEC-3G isoform 1 | 3 | 1 | 0 | 4 |
neuropeptide S receptor isoform A | 8 | 0 | 0 | 8 |
ATP-binding cassette sub-family C member 3 | 0 | 26 | 0 | 26 |
Multidrug resistance-associated protein 4 | 0 | 26 | 0 | 28 |
Bile salt export pump | 0 | 43 | 0 | 43 |
Interferon beta | 31 | 0 | 0 | 31 |
Integrin beta-3 | 10 | 0 | 0 | 10 |
Integrin alpha-IIb | 10 | 0 | 0 | 10 |
Methionine aminopeptidase | 0 | 5 | 0 | 5 |
Fatty-acid amide hydrolase 1 | 0 | 5 | 0 | 5 |
Inositol monophosphatase 1 | 7 | 0 | 0 | 7 |
Canalicular multispecific organic anion transporter 1 | 0 | 26 | 0 | 26 |
ATPase family AAA domain-containing protein 5 | 21 | 0 | 0 | 21 |
Ataxin-2 | 25 | 0 | 0 | 25 |
cytochrome P450 family 3 subfamily A polypeptide 4 | 28 | 0 | 0 | 28 |
EWS/FLI fusion protein | 20 | 0 | 0 | 21 |
cytochrome P450 2D6 | 27 | 0 | 0 | 27 |
Chain A, retinol dehydratase | 0 | 1 | 0 | 1 |
acetylcholinesterase | 26 | 0 | 0 | 26 |
histone acetyltransferase KAT2A isoform 1 | 11 | 0 | 0 | 11 |
Gamma-aminobutyric acid receptor subunit pi | 22 | 4 | 0 | 26 |
Sex hormone-binding globulin | 0 | 1 | 4 | 5 |
Corticosteroid-binding globulin | 0 | 5 | 0 | 5 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 4 | 0 | 4 |
Androgen receptor | 0 | 11 | 1 | 12 |
Gamma-aminobutyric acid receptor subunit beta-1 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit delta | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 22 | 4 | 0 | 26 |
Solute carrier organic anion transporter family member 1A1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit beta-3 | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit beta-2 | 22 | 4 | 0 | 26 |
TAR DNA-binding protein 43 | 14 | 0 | 0 | 14 |
G-protein coupled bile acid receptor 1 | 0 | 0 | 4 | 4 |
GABA theta subunit | 22 | 4 | 0 | 26 |
Gamma-aminobutyric acid receptor subunit epsilon | 22 | 4 | 0 | 26 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
Chain E, LYSINE, ARGININE, ORNITHINE-BINDING PROTEIN | 0 | 0 | 1 | 1 |
phosphopantetheinyl transferase | 12 | 0 | 0 | 12 |
NFKB1 protein, partial | 3 | 0 | 0 | 3 |
GLS protein | 13 | 0 | 0 | 13 |
thyroid stimulating hormone receptor | 26 | 0 | 0 | 26 |
cytochrome P450 2C19 precursor | 9 | 0 | 0 | 9 |
muscarinic acetylcholine receptor M1 | 13 | 0 | 0 | 13 |
lethal factor (plasmid) | 11 | 0 | 0 | 11 |
Cytochrome P450 3A4 | 0 | 12 | 1 | 16 |
Nitric oxide synthase, endothelial | 0 | 0 | 0 | 2 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, brain | 0 | 0 | 0 | 1 |
Nitric oxide synthase, inducible | 0 | 1 | 0 | 2 |
Nitric oxide synthase, inducible | 0 | 0 | 1 | 3 |
Cationic amino acid transporter 3 | 0 | 1 | 0 | 1 |
ATP-dependent phosphofructokinase | 18 | 0 | 0 | 18 |
Chain A, Hyaluronidase, phage associated | 0 | 1 | 0 | 1 |
thioredoxin glutathione reductase | 8 | 0 | 0 | 8 |
lethal(3)malignant brain tumor-like protein 1 isoform I | 4 | 0 | 0 | 4 |
Polyphenol oxidase 2 | 0 | 1 | 0 | 1 |
Pancreatic alpha-amylase | 0 | 2 | 0 | 2 |
Albumin | 0 | 1 | 0 | 2 |
Urease | 0 | 1 | 0 | 1 |
Prolyl 4-hydroxylase subunit alpha-1 | 0 | 0 | 0 | 1 |
Tyrosinase | 0 | 2 | 0 | 2 |
Alpha-2B adrenergic receptor | 0 | 19 | 2 | 21 |
Spike glycoprotein | 19 | 2 | 2 | 23 |
Hyaluronate lyase | 0 | 1 | 0 | 1 |
Prolyl hydroxylase EGLN2 | 0 | 0 | 0 | 1 |
Egl nine homolog 1 | 0 | 1 | 1 | 3 |
Prolyl hydroxylase EGLN3 | 0 | 0 | 0 | 1 |
Hypoxia-inducible factor 1-alpha inhibitor | 0 | 0 | 0 | 1 |
Solute carrier family 23 member 1 | 0 | 1 | 0 | 1 |
interleukin 8 | 8 | 0 | 0 | 8 |
SMAD family member 2 | 18 | 0 | 0 | 18 |
SMAD family member 3 | 18 | 0 | 0 | 18 |
G | 19 | 0 | 0 | 19 |
P53 | 2 | 0 | 0 | 2 |
arylsulfatase A | 15 | 0 | 0 | 15 |
thyroid stimulating hormone receptor | 22 | 0 | 0 | 22 |
Bloom syndrome protein isoform 1 | 12 | 0 | 0 | 12 |
peripheral myelin protein 22 isoform 1 | 10 | 0 | 0 | 10 |
hemoglobin subunit beta | 2 | 0 | 0 | 2 |
cytochrome P450 3A4 isoform 1 | 22 | 0 | 0 | 22 |
M-phase phosphoprotein 8 | 11 | 0 | 0 | 11 |
Bile salt export pump | 0 | 6 | 0 | 6 |
HLA class I histocompatibility antigen, B alpha chain | 19 | 0 | 0 | 19 |
Nuclear receptor ROR-gamma | 14 | 0 | 0 | 14 |
Inositol hexakisphosphate kinase 1 | 19 | 0 | 0 | 19 |
Protein-arginine deiminase type-4 | 0 | 3 | 0 | 3 |
cytochrome P450 2C9, partial | 19 | 0 | 0 | 19 |
Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
Chain A, GTPase KRas, isoform 2B | 0 | 0 | 1 | 1 |
Membrane primary amine oxidase | 0 | 2 | 0 | 2 |
Cytochrome P450 2B1 | 0 | 1 | 0 | 2 |
Cytochrome P450 1A1 | 0 | 1 | 0 | 2 |
GTPase KRas | 0 | 0 | 2 | 2 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 2 | 0 | 4 |
Glutaminyl-peptide cyclotransferase | 0 | 2 | 0 | 2 |
Lanosterol 14-alpha demethylase | 0 | 4 | 1 | 5 |
Membrane primary amine oxidase | 0 | 1 | 0 | 1 |
Glutaminyl-peptide cyclotransferase | 0 | 1 | 0 | 1 |
pregnane X receptor | 13 | 0 | 0 | 13 |
galanin receptor type 3 | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 13 | 2 | 22 |
Glycine receptor subunit alpha-1 | 0 | 12 | 0 | 12 |
Glycine receptor subunit beta | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-2 | 0 | 12 | 0 | 12 |
Glycine receptor subunit alpha-3 | 0 | 12 | 0 | 12 |
ORF73 | 0 | 0 | 1 | 1 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
Chain A, HADH2 protein | 16 | 0 | 0 | 16 |
Chain B, HADH2 protein | 16 | 0 | 0 | 16 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
Chain A, Estrogen-related receptor gamma | 0 | 0 | 1 | 1 |
GALC protein | 6 | 0 | 0 | 6 |
nuclear factor of kappa light polypeptide gene enhancer in B-cells 1 (p105), isoform CRA_a | 14 | 0 | 0 | 14 |
potassium voltage-gated channel subfamily H member 2 isoform d | 15 | 0 | 0 | 15 |
Estrogen receptor | 0 | 8 | 3 | 12 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 1 | 0 | 4 | 0 | 4 |
Aldo-keto reductase family 1 member B1 | 0 | 19 | 0 | 19 |
Androgen receptor | 0 | 5 | 3 | 11 |
Polyunsaturated fatty acid lipoxygenase ALOX15 | 0 | 3 | 0 | 3 |
Sodium-dependent noradrenaline transporter | 0 | 18 | 1 | 19 |
Sodium-dependent serotonin transporter | 0 | 14 | 1 | 15 |
5-hydroxytryptamine receptor 6 | 0 | 8 | 0 | 8 |
Estrogen-related receptor gamma | 0 | 2 | 1 | 3 |
Sodium-dependent dopamine transporter | 0 | 14 | 0 | 14 |
GTP-binding protein Rheb | 0 | 0 | 1 | 1 |
Estrogen receptor beta | 0 | 7 | 3 | 10 |
Chain A, 2-oxoglutarate Oxygenase | 14 | 0 | 0 | 14 |
Chain A, ATP-DEPENDENT DNA HELICASE Q1 | 4 | 0 | 0 | 4 |
Chain A, Cruzipain | 9 | 0 | 0 | 9 |
calpain II, partial | 0 | 1 | 0 | 1 |
15-lipoxygenase, partial | 6 | 0 | 0 | 6 |
Mcl-1 | 0 | 2 | 0 | 2 |
Estrogen receptor 1 | 0 | 1 | 0 | 1 |
hypoxia-inducible factor 1, alpha subunit (basic helix-loop-helix transcription factor) | 15 | 0 | 0 | 15 |
envelope glycoprotein | 0 | 1 | 0 | 1 |
nonstructural protein 1 | 7 | 0 | 0 | 7 |
bromodomain adjacent to zinc finger domain 2B | 13 | 0 | 0 | 13 |
thyrotropin-releasing hormone receptor | 5 | 0 | 0 | 5 |
polyunsaturated fatty acid lipoxygenase ALOX12 | 2 | 0 | 0 | 2 |
estrogen receptor beta isoform 1 | 0 | 1 | 0 | 1 |
huntingtin isoform 2 | 7 | 0 | 0 | 7 |
DNA polymerase beta | 9 | 0 | 0 | 9 |
nuclear factor NF-kappa-B p105 subunit isoform 1 | 2 | 0 | 0 | 2 |
nuclear receptor ROR-gamma isoform 1 | 18 | 0 | 0 | 18 |
caspase-1 isoform alpha precursor | 2 | 0 | 0 | 2 |
Solute carrier family 22 member 2 | 0 | 5 | 0 | 8 |
Solute carrier family 22 member 1 | 0 | 9 | 0 | 12 |
Polyunsaturated fatty acid lipoxygenase ALOX15B | 9 | 0 | 0 | 9 |
5-hydroxytryptamine receptor 4 | 0 | 16 | 0 | 16 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 1 | 4 | 5 |
Solute carrier family 22 member 3 | 0 | 5 | 0 | 6 |
Epidermal growth factor receptor | 0 | 5 | 0 | 5 |
Receptor tyrosine-protein kinase erbB-2 | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase Lck | 0 | 2 | 0 | 2 |
Muscarinic acetylcholine receptor M1 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M3 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M4 | 0 | 4 | 0 | 4 |
Muscarinic acetylcholine receptor M5 | 0 | 4 | 0 | 4 |
Alpha-2A adrenergic receptor | 0 | 23 | 1 | 24 |
60 kDa chaperonin | 0 | 2 | 0 | 2 |
Replicase polyprotein 1a | 0 | 3 | 2 | 5 |
Adenosine receptor A3 | 0 | 6 | 0 | 6 |
60 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Muscarinic acetylcholine receptor M2 | 0 | 4 | 0 | 4 |
Alpha-1B adrenergic receptor | 0 | 13 | 0 | 13 |
Alpha-2C adrenergic receptor | 0 | 13 | 1 | 14 |
5-hydroxytryptamine receptor 1A | 0 | 13 | 0 | 13 |
Substance-K receptor | 0 | 10 | 0 | 10 |
Thromboxane-A synthase | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2C | 0 | 16 | 0 | 16 |
Mitogen-activated protein kinase 1 | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1B | 0 | 10 | 0 | 10 |
Adenosine receptor A2a | 0 | 8 | 0 | 8 |
Mu-type opioid receptor | 0 | 8 | 1 | 9 |
D(3) dopamine receptor | 0 | 16 | 1 | 19 |
5-hydroxytryptamine receptor 2B | 0 | 12 | 0 | 12 |
Alpha-1A adrenergic receptor | 0 | 13 | 1 | 14 |
Histamine H2 receptor | 14 | 2 | 2 | 20 |
Caspase-7 | 2 | 0 | 0 | 2 |
10 kDa heat shock protein, mitochondrial | 0 | 3 | 0 | 3 |
Pup--protein ligase | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor alpha | 1 | 0 | 0 | 1 |
Thiosulfate sulfurtransferase | 0 | 2 | 0 | 2 |
60 kDa chaperonin | 0 | 3 | 0 | 3 |
10 kDa chaperonin | 0 | 3 | 0 | 3 |
Multidrug and toxin extrusion protein 2 | 0 | 4 | 0 | 4 |
Multidrug and toxin extrusion protein 1 | 0 | 8 | 0 | 8 |
M1-family alanyl aminopeptidase | 0 | 1 | 0 | 1 |
large T antigen | 0 | 3 | 0 | 3 |
Vpr | 3 | 0 | 0 | 3 |
Albumin | 0 | 0 | 4 | 4 |
Major prion protein | 0 | 0 | 4 | 4 |
Sodium channel protein type 1 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 2 | 0 | 2 |
Sodium channel protein type 3 subunit alpha | 0 | 1 | 0 | 1 |
Cytochrome P450 2C9 | 0 | 10 | 0 | 10 |
UDP-glucuronosyltransferase 2B7 | 0 | 2 | 0 | 6 |
Cytochrome P450 2B6 | 0 | 2 | 1 | 3 |
Sodium channel protein type 4 subunit alpha | 0 | 3 | 0 | 5 |
Cytochrome P450 2J2 | 0 | 5 | 0 | 5 |
Potassium voltage-gated channel subfamily H member 2 | 0 | 17 | 0 | 18 |
Sodium channel protein type 9 subunit alpha | 0 | 4 | 0 | 4 |
Frizzled-8 | 0 | 0 | 1 | 1 |
P2X purinoceptor 4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 3 | 0 | 3 |
Translocator protein | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 3 | 0 | 3 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 3 | 0 | 3 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 3 | 0 | 3 |
Histamine H1 receptor | 0 | 12 | 2 | 14 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 4 | 0 | 5 | 0 | 6 |
Carbonic anhydrase | 0 | 2 | 0 | 3 |
Carbonic anhydrase 15 | 0 | 2 | 0 | 3 |
PPM1D protein | 14 | 0 | 0 | 14 |
glucose-6-phosphate dehydrogenase-6-phosphogluconolactonase | 0 | 3 | 0 | 3 |
Spike glycoprotein | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
glucose-6-phosphate 1-dehydrogenase isoform b | 0 | 3 | 0 | 3 |
Transmembrane protease serine 2 | 0 | 2 | 2 | 4 |
Dihydrofolate reductase | 0 | 2 | 0 | 2 |
DNA ligase | 0 | 1 | 0 | 1 |
Riboflavin-binding protein | 0 | 1 | 2 | 3 |
Amyloid-beta precursor protein | 0 | 3 | 0 | 4 |
Histidine-rich protein PFHRP-II | 0 | 2 | 0 | 3 |
Procathepsin L | 0 | 3 | 2 | 5 |
Muscarinic acetylcholine receptor M2 | 0 | 13 | 0 | 13 |
Muscarinic acetylcholine receptor M4 | 0 | 11 | 0 | 11 |
Muscarinic acetylcholine receptor M5 | 0 | 12 | 0 | 12 |
Replicase polyprotein 1ab | 0 | 2 | 2 | 4 |
Replicase polyprotein 1ab | 0 | 4 | 3 | 7 |
Spike glycoprotein | 0 | 1 | 0 | 1 |
Replicase polyprotein 1ab | 0 | 5 | 3 | 8 |
Muscarinic acetylcholine receptor M1 | 0 | 12 | 0 | 12 |
Ribosyldihydronicotinamide dehydrogenase [quinone] | 0 | 1 | 0 | 1 |
DNA ligase 1 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor M3 | 0 | 12 | 0 | 12 |
Serine/threonine-protein kinase mTOR | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 4 group A member 2 | 0 | 0 | 1 | 1 |
Beta-secretase 1 | 0 | 2 | 0 | 2 |
Calcium-dependent protein kinase 1 | 0 | 0 | 1 | 1 |
MO15-related protein kinase Pfmrk | 0 | 1 | 0 | 1 |
DNA ligase A | 0 | 1 | 0 | 1 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Phosphoethanolamine N-methyltransferase | 0 | 1 | 0 | 1 |
Sigma non-opioid intracellular receptor 1 | 0 | 7 | 1 | 8 |
Angiotensin-converting enzyme 2 | 0 | 2 | 2 | 4 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
Cysteine proteinase falcipain 2a | 0 | 1 | 0 | 1 |
atrial natriuretic peptide receptor 1 precursor | 6 | 0 | 0 | 6 |
atrial natriuretic peptide receptor 2 precursor | 3 | 0 | 0 | 3 |
MBT domain-containing protein 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 1 | 0 | 5 | 0 | 6 |
Lethal(3)malignant brain tumor-like protein 4 | 0 | 1 | 0 | 1 |
Lethal(3)malignant brain tumor-like protein 3 | 0 | 1 | 0 | 1 |
Chloroquine resistance transporter | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 2 | 0 | 4 | 0 | 5 |
Lethal(3)malignant brain tumor-like protein 1 | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Chain A, Glycogen phosphorylase, muscle form | 0 | 1 | 0 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Chain A, Transthyretin | 0 | 0 | 1 | 1 |
Chain B, Transthyretin | 0 | 0 | 1 | 1 |
Nrf2 | 2 | 0 | 0 | 2 |
BRCA1 | 4 | 0 | 0 | 4 |
Neuraminidase | 0 | 1 | 0 | 1 |
cytochrome P450 2D6 isoform 1 | 12 | 0 | 0 | 12 |
nuclear receptor subfamily 0 group B member 1 | 0 | 1 | 0 | 1 |
cytochrome P450 2C9 precursor | 7 | 0 | 0 | 7 |
parathyroid hormone/parathyroid hormone-related peptide receptor precursor | 5 | 0 | 0 | 5 |
glycogen synthase kinase-3 beta isoform 1 | 0 | 0 | 1 | 1 |
steroidogenic factor 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 2 | 0 | 2 |
Carbonic anhydrase 12 | 0 | 3 | 0 | 4 |
G2/mitotic-specific cyclin-B2 | 0 | 1 | 0 | 1 |
Triosephosphate isomerase | 0 | 1 | 0 | 1 |
Cytochrome P450 1A1 | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 1 | 0 | 5 | 0 | 6 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
Seed linoleate 13S-lipoxygenase-1 | 0 | 2 | 0 | 4 |
ATP-dependent translocase ABCB1 | 0 | 8 | 3 | 13 |
Calmodulin-1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2D6 | 0 | 7 | 0 | 7 |
Serine/threonine-protein kinase pim-1 | 0 | 2 | 0 | 2 |
Aromatase | 0 | 7 | 0 | 8 |
G2/mitotic-specific cyclin-B1 | 0 | 1 | 0 | 1 |
Urease subunit alpha | 0 | 2 | 0 | 2 |
Aldo-keto reductase family 1 member B1 | 0 | 5 | 0 | 5 |
G2/mitotic-specific cyclin-B | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B1 | 0 | 3 | 0 | 3 |
Carbonyl reductase [NADPH] 1 | 0 | 2 | 0 | 3 |
Glycogen synthase kinase-3 beta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 2 | 0 | 2 |
Casein kinase II subunit alpha' | 0 | 1 | 0 | 1 |
Amine oxidase [flavin-containing] A | 0 | 7 | 0 | 7 |
Amine oxidase [flavin-containing] B | 0 | 5 | 0 | 5 |
Proteasome subunit beta type-5 | 0 | 2 | 0 | 2 |
Substance-P receptor | 0 | 3 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 6 | 1 | 7 |
Receptor-type tyrosine-protein kinase FLT3 | 0 | 2 | 0 | 2 |
Carbonic anhydrase 7 | 0 | 3 | 0 | 4 |
Gamma-aminobutyric acid receptor subunit beta-2 | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 2 | 0 | 2 |
Glycogen synthase kinase-3 alpha | 0 | 1 | 0 | 1 |
Glycogen synthase kinase-3 beta | 0 | 3 | 0 | 3 |
Death-associated protein kinase 1 | 0 | 1 | 0 | 1 |
Mitogen-activated protein kinase 10 | 0 | 1 | 0 | 1 |
Casein kinase II subunit beta | 0 | 1 | 0 | 1 |
Casein kinase II subunit alpha | 0 | 1 | 0 | 1 |
Urease subunit beta | 0 | 2 | 0 | 2 |
Gamma-aminobutyric acid receptor subunit epsilon | 0 | 2 | 0 | 2 |
Xanthine dehydrogenase/oxidase | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 6 | 0 | 1 | 0 | 1 |
Cyclin-dependent-like kinase 5 | 0 | 1 | 0 | 1 |
Cyclin homolog | 0 | 1 | 0 | 1 |
Lactoylglutathione lyase | 0 | 4 | 0 | 4 |
Cyclin-dependent kinase 5 activator 1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 2 | 0 | 2 |
Cytochrome P450 1B1 | 0 | 3 | 0 | 3 |
Carbonic anhydrase 9 | 0 | 5 | 0 | 6 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Integrase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 2 | 0 | 2 |
Casein kinase II subunit alpha 3 | 0 | 1 | 0 | 1 |
G2/mitotic-specific cyclin-B3 | 0 | 1 | 0 | 1 |
3-oxoacyl-acyl-carrier protein reductase | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 2 | 0 | 2 |
Cyclin-dependent kinase 1 | 0 | 1 | 0 | 1 |
P2Y purinoceptor 12 | 0 | 2 | 0 | 2 |
Dipeptidyl peptidase 3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 2 | 0 | 2 |
Broad substrate specificity ATP-binding cassette transporter ABCG2 | 0 | 4 | 0 | 4 |
Sialidase-2 | 0 | 2 | 0 | 2 |
Solute carrier family 22 member 1 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 6 | 0 | 4 | 0 | 4 |
Solute carrier family 22 member 2 | 0 | 1 | 0 | 1 |
cGMP-specific 3',5'-cyclic phosphodiesterase | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Potassium-transporting ATPase alpha chain 1 | 0 | 1 | 0 | 1 |
ATP-dependent translocase ABCB1 | 0 | 3 | 0 | 3 |
Histamine H2 receptor | 0 | 15 | 2 | 17 |
Histamine H1 receptor | 0 | 2 | 4 | 7 |
Potassium-transporting ATPase subunit beta | 0 | 1 | 0 | 1 |
Aldehyde oxidase | 0 | 3 | 0 | 3 |
Solute carrier family 22 member 6 | 0 | 3 | 0 | 4 |
Solute carrier family 22 member 8 | 0 | 4 | 0 | 6 |
Histamine H4 receptor | 0 | 3 | 2 | 5 |
Solute carrier family 22 member 11 | 0 | 1 | 0 | 2 |
Solute carrier family 22 member 4 | 0 | 1 | 0 | 1 |
Solute carrier family 22 member 8 | 0 | 2 | 0 | 2 |
regulator of G-protein signaling 4 | 14 | 0 | 0 | 14 |
Beta-1 adrenergic receptor | 0 | 0 | 1 | 1 |
Alpha-1B adrenergic receptor | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 4 | 2 | 6 |
Alpha-1A adrenergic receptor | 0 | 0 | 1 | 1 |
D | 0 | 5 | 0 | 5 |
D(3) dopamine receptor | 0 | 5 | 0 | 5 |
Alpha-2B adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-2C adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-2A adrenergic receptor | 0 | 5 | 0 | 5 |
Alpha-1D adrenergic receptor | 0 | 7 | 0 | 7 |
Alpha-1D adrenergic receptor | 0 | 14 | 1 | 15 |
D(1B) dopamine receptor | 0 | 4 | 0 | 4 |
Adenosine receptor A2b | 0 | 0 | 1 | 1 |
Adenosine receptor A2a | 0 | 1 | 1 | 3 |
Alpha-2B adrenergic receptor | 0 | 0 | 0 | 1 |
D(4) dopamine receptor | 0 | 4 | 0 | 4 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Alpha-1A adrenergic receptor | 0 | 4 | 1 | 5 |
Alpha-1B adrenergic receptor | 0 | 3 | 1 | 4 |
5-hydroxytryptamine receptor 7 | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 7 | 1 | 8 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
Alpha-2C adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 0 | 0 | 1 |
Alpha-2A adrenergic receptor | 0 | 1 | 0 | 1 |
Nischarin | 0 | 2 | 0 | 2 |
Nischarin | 0 | 1 | 0 | 1 |
endonuclease IV | 6 | 0 | 0 | 6 |
dopamine D1 receptor | 4 | 0 | 0 | 4 |
Potassium voltage-gated channel subfamily A member 1 | 0 | 0 | 1 | 1 |
DNA dC->dU-editing enzyme APOBEC-3F isoform a | 3 | 0 | 0 | 3 |
Carbonic anhydrase 3 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 6 | 0 | 4 | 0 | 5 |
Carbonic anhydrase 5A, mitochondrial | 0 | 4 | 0 | 7 |
Carbonic anhydrase 13 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 14 | 0 | 2 | 0 | 3 |
Carbonic anhydrase 5B, mitochondrial | 0 | 2 | 0 | 5 |
Sodium- and chloride-dependent creatine transporter 1 | 0 | 1 | 0 | 1 |
Chain A, Breast cancer type 1 susceptibility protein | 1 | 0 | 0 | 1 |
Chain A, Putative fructose-1,6-bisphosphate aldolase | 9 | 0 | 0 | 9 |
alkaline phosphatase, intestinal | 0 | 1 | 1 | 2 |
apical membrane antigen 1, AMA1 | 5 | 0 | 0 | 5 |
PINK1 | 2 | 0 | 0 | 2 |
glucocerebrosidase | 8 | 0 | 0 | 8 |
Parkin | 3 | 0 | 0 | 3 |
toll-like receptor 9 | 0 | 1 | 0 | 1 |
heat shock 70kDa protein 5 (glucose-regulated protein, 78kDa) | 6 | 0 | 0 | 6 |
TPA: protein transporter TIM10 | 0 | 1 | 0 | 1 |
lysosomal alpha-glucosidase preproprotein | 4 | 0 | 0 | 4 |
alkaline phosphatase, tissue-nonspecific isozyme isoform 1 preproprotein | 0 | 1 | 1 | 2 |
perilipin-5 | 0 | 1 | 0 | 1 |
intestinal alkaline phosphatase precursor | 0 | 1 | 1 | 2 |
perilipin-1 | 0 | 1 | 0 | 1 |
pyruvate kinase PKM isoform a | 3 | 0 | 0 | 3 |
histone-lysine N-methyltransferase 2A isoform 2 precursor | 4 | 0 | 0 | 4 |
tumor susceptibility gene 101 protein | 2 | 0 | 0 | 2 |
1-acylglycerol-3-phosphate O-acyltransferase ABHD5 isoform a | 0 | 1 | 0 | 1 |
alkaline phosphatase, germ cell type preproprotein | 0 | 1 | 1 | 2 |
hypothetical protein SA1422 | 0 | 1 | 0 | 1 |
Prostaglandin E synthase | 0 | 2 | 0 | 2 |
Histone deacetylase 3 | 0 | 3 | 0 | 3 |
Acetylcholinesterase | 0 | 1 | 0 | 1 |
Lysine-specific histone demethylase 1A | 0 | 1 | 0 | 1 |
D-amino-acid oxidase | 0 | 1 | 0 | 1 |
Phospholipase A2 | 0 | 1 | 0 | 1 |
Neuronal proto-oncogene tyrosine-protein kinase Src | 0 | 1 | 0 | 1 |
Cholinesterase | 0 | 2 | 0 | 2 |
Heme oxygenase 1 | 0 | 1 | 0 | 1 |
Glutathione S-transferase P | 0 | 1 | 0 | 1 |
Polyunsaturated fatty acid 5-lipoxygenase | 0 | 4 | 0 | 4 |
Microtubule-associated protein tau | 0 | 2 | 1 | 4 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 1 | 0 | 1 |
Tissue factor | 0 | 2 | 0 | 2 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Aminopeptidase N | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 2 | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 2 | 0 | 2 |
Heme oxygenase 2 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 1 | 0 | 1 |
17-beta-hydroxysteroid dehydrogenase type 2 | 0 | 1 | 0 | 1 |
Alpha-synuclein | 7 | 1 | 1 | 9 |
Histone deacetylase 4 | 0 | 3 | 0 | 3 |
Cholinesterase | 0 | 2 | 0 | 2 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 1 | 0 | 1 |
Histone acetyltransferase p300 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase PAK 1 | 0 | 1 | 0 | 1 |
Histone deacetylase 1 | 0 | 4 | 0 | 4 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 1 | 2 |
Sodium/bile acid cotransporter | 0 | 1 | 1 | 2 |
Nuclear factor erythroid 2-related factor 2 | 0 | 0 | 1 | 1 |
Thioredoxin reductase 1, cytoplasmic | 0 | 2 | 0 | 3 |
Thioredoxin reductase 3 | 0 | 1 | 0 | 1 |
Sortase A | 0 | 1 | 0 | 1 |
Histone deacetylase 7 | 0 | 3 | 0 | 3 |
Histone deacetylase 2 | 0 | 4 | 0 | 4 |
CREB-binding protein | 0 | 1 | 0 | 1 |
Sarcoplasmic/endoplasmic reticulum calcium ATPase 3 | 0 | 2 | 0 | 2 |
Cysteine protease | 0 | 1 | 0 | 1 |
Polyamine deacetylase HDAC10 | 0 | 3 | 0 | 3 |
Histone deacetylase 11 | 0 | 3 | 0 | 3 |
NACHT, LRR and PYD domains-containing protein 3 | 0 | 1 | 0 | 1 |
Histone deacetylase 8 | 0 | 4 | 0 | 4 |
Thioredoxin reductase 2, mitochondrial | 0 | 1 | 0 | 1 |
CDGSH iron-sulfur domain-containing protein 1 | 0 | 2 | 0 | 2 |
Histone deacetylase 6 | 0 | 3 | 0 | 3 |
Histone deacetylase 9 | 0 | 3 | 0 | 3 |
Histone deacetylase 5 | 0 | 3 | 0 | 3 |
Lymphocyte antigen 96 | 0 | 0 | 1 | 1 |
Beta lactamase (plasmid) | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Beta-glucuronidase | 0 | 1 | 0 | 1 |
Glucose-6-phosphate 1-dehydrogenase | 0 | 1 | 0 | 1 |
NPC1-like intracellular cholesterol transporter 1 | 0 | 0 | 1 | 1 |
Chain A, STEROID DELTA-ISOMERASE | 0 | 0 | 1 | 1 |
Steroid Delta-isomerase | 0 | 0 | 1 | 1 |
Vitamin D3 receptor | 0 | 1 | 1 | 2 |
Ileal sodium/bile acid cotransporter | 0 | 1 | 0 | 1 |
Bile acid receptor | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 16 | 0 | 16 |
Histamine H3 receptor | 0 | 1 | 0 | 2 |
Hsf1 protein | 0 | 0 | 2 | 3 |
ubiquitin carboxyl-terminal hydrolase 2 isoform a | 5 | 0 | 0 | 5 |
high affinity choline transporter 1 isoform a | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Fyn | 0 | 2 | 0 | 2 |
Beta-1 adrenergic receptor | 0 | 4 | 0 | 4 |
D(2) dopamine receptor | 0 | 10 | 1 | 13 |
D(1A) dopamine receptor | 0 | 8 | 0 | 9 |
Prostaglandin G/H synthase 1 | 0 | 4 | 0 | 4 |
Adenosine receptor A1 | 0 | 4 | 0 | 4 |
Vasopressin V1a receptor | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 6 | 0 | 6 |
Kappa-type opioid receptor | 0 | 4 | 0 | 4 |
Disintegrin and metalloproteinase domain-containing protein 17 | 3 | 0 | 0 | 3 |
UDP-glucose 4-epimerase | 0 | 1 | 0 | 1 |
Cysteinyl leukotriene receptor 1 | 0 | 2 | 0 | 2 |
Chain A, Sex Hormone-Binding Globulin | 0 | 0 | 1 | 1 |
Plasma kallikrein | 0 | 1 | 0 | 2 |
Progesterone receptor | 0 | 1 | 0 | 1 |
Progesterone receptor | 0 | 4 | 1 | 6 |
Glucocorticoid receptor | 0 | 2 | 1 | 3 |
Mineralocorticoid receptor | 0 | 3 | 1 | 4 |
Sex hormone-binding globulin | 0 | 1 | 0 | 1 |
Androgen receptor | 0 | 1 | 1 | 2 |
Mineralocorticoid receptor | 0 | 1 | 0 | 1 |
Testosterone 17-beta-dehydrogenase 3 | 0 | 1 | 0 | 1 |
Angiotensin-converting enzyme | 0 | 0 | 1 | 1 |
Cannabinoid receptor 2 | 0 | 1 | 0 | 1 |
Muscarinic acetylcholine receptor | 0 | 1 | 0 | 1 |
Neuropeptide FF receptor 2 | 0 | 0 | 0 | 1 |
ALK tyrosine kinase receptor | 0 | 1 | 0 | 1 |
prostaglandin E2 receptor EP2 subtype | 1 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A5 | 0 | 0 | 0 | 1 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP1 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP4 subtype | 0 | 2 | 1 | 3 |
Prostaglandin F2-alpha receptor | 0 | 0 | 1 | 1 |
Prostaglandin E2 receptor EP4 subtype | 0 | 1 | 1 | 2 |
Prostaglandin E2 receptor EP3 subtype | 0 | 2 | 1 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 1 | 3 |
Prostacyclin receptor | 0 | 2 | 1 | 3 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 1 | 0 | 3 |
Prostaglandin E2 receptor EP2 subtype | 0 | 2 | 0 | 2 |
Prostaglandin E2 receptor EP2 subtype | 0 | 1 | 1 | 2 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 2A1 | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1B2 | 0 | 0 | 0 | 1 |
Solute carrier family 22 member 7 | 0 | 0 | 0 | 1 |
Genome polyprotein | 0 | 1 | 1 | 2 |
chaperonin-containing TCP-1 beta subunit homolog | 3 | 0 | 0 | 3 |
hypothetical protein, conserved | 4 | 0 | 0 | 4 |
eyes absent homolog 2 isoform a | 2 | 0 | 0 | 2 |
relaxin receptor 1 isoform 1 | 2 | 0 | 0 | 2 |
Flavin reductase (NADPH) | 0 | 0 | 1 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 3 | 0 | 3 |
Cytochrome P450 11B1, mitochondrial | 0 | 2 | 0 | 2 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 11B2, mitochondrial | 0 | 2 | 0 | 2 |
Cytochrome P450 11B2, mitochondrial | 0 | 1 | 0 | 1 |
Caspase-7 | 2 | 0 | 0 | 2 |
caspase-3 | 2 | 0 | 0 | 2 |
Rap guanine nucleotide exchange factor 3 | 4 | 0 | 0 | 4 |
Nuclear receptor subfamily 1 group I member 2 | 0 | 0 | 2 | 2 |
Chain A, Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Thymidylate synthase | 0 | 2 | 0 | 2 |
Thymidylate synthase | 0 | 1 | 0 | 2 |
Dihydrofolate reductase | 0 | 0 | 1 | 1 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Solute carrier organic anion transporter family member 1A3 | 0 | 3 | 0 | 3 |
Folylpolyglutamate synthase, mitochondrial | 0 | 0 | 0 | 1 |
Multidrug resistance associated protein | 0 | 0 | 0 | 1 |
Menin | 0 | 0 | 1 | 1 |
Lecithin retinol acyltransferase | 0 | 1 | 0 | 1 |
30S ribosomal protein S6 | 0 | 2 | 0 | 2 |
30S ribosomal protein S7 | 0 | 2 | 0 | 2 |
50S ribosomal protein L15 | 0 | 2 | 0 | 2 |
50S ribosomal protein L10 | 0 | 2 | 0 | 2 |
50S ribosomal protein L11 | 0 | 2 | 0 | 2 |
50S ribosomal protein L7/L12 | 0 | 2 | 0 | 2 |
50S ribosomal protein L19 | 0 | 2 | 0 | 2 |
50S ribosomal protein L1 | 0 | 2 | 0 | 2 |
50S ribosomal protein L20 | 0 | 2 | 0 | 2 |
50S ribosomal protein L27 | 0 | 2 | 0 | 2 |
50S ribosomal protein L28 | 0 | 2 | 0 | 2 |
50S ribosomal protein L29 | 0 | 2 | 0 | 2 |
50S ribosomal protein L31 | 0 | 2 | 0 | 2 |
50S ribosomal protein L31 type B | 0 | 2 | 0 | 2 |
50S ribosomal protein L32 | 0 | 2 | 0 | 2 |
50S ribosomal protein L33 | 0 | 2 | 0 | 2 |
50S ribosomal protein L34 | 0 | 2 | 0 | 2 |
50S ribosomal protein L35 | 0 | 2 | 0 | 2 |
50S ribosomal protein L36 | 0 | 2 | 0 | 2 |
30S ribosomal protein S10 | 0 | 2 | 0 | 2 |
30S ribosomal protein S11 | 0 | 2 | 0 | 2 |
30S ribosomal protein S12 | 0 | 2 | 0 | 2 |
30S ribosomal protein S13 | 0 | 2 | 0 | 2 |
30S ribosomal protein S16 | 0 | 2 | 0 | 2 |
30S ribosomal protein S18 | 0 | 2 | 0 | 2 |
30S ribosomal protein S19 | 0 | 2 | 0 | 2 |
30S ribosomal protein S20 | 0 | 2 | 0 | 2 |
30S ribosomal protein S2 | 0 | 2 | 0 | 2 |
30S ribosomal protein S3 | 0 | 2 | 0 | 2 |
30S ribosomal protein S4 | 0 | 2 | 0 | 2 |
30S ribosomal protein S5 | 0 | 2 | 0 | 2 |
30S ribosomal protein S8 | 0 | 2 | 0 | 2 |
30S ribosomal protein S9 | 0 | 2 | 0 | 2 |
50S ribosomal protein L13 | 0 | 2 | 0 | 2 |
50S ribosomal protein L14 | 0 | 2 | 0 | 2 |
50S ribosomal protein L16 | 0 | 2 | 0 | 2 |
50S ribosomal protein L23 | 0 | 2 | 0 | 2 |
30S ribosomal protein S15 | 0 | 2 | 0 | 2 |
50S ribosomal protein L17 | 0 | 2 | 0 | 2 |
50S ribosomal protein L21 | 0 | 2 | 0 | 2 |
50S ribosomal protein L30 | 0 | 2 | 0 | 2 |
50S ribosomal protein L6 | 0 | 2 | 0 | 2 |
30S ribosomal protein S14 | 0 | 2 | 0 | 2 |
30S ribosomal protein S17 | 0 | 2 | 0 | 2 |
30S ribosomal protein S1 | 0 | 2 | 0 | 2 |
50S ribosomal protein L18 | 0 | 2 | 0 | 2 |
Lethal factor | 0 | 1 | 0 | 1 |
50S ribosomal protein L2 | 0 | 2 | 0 | 2 |
50S ribosomal protein L3 | 0 | 2 | 0 | 2 |
50S ribosomal protein L24 | 0 | 2 | 0 | 2 |
50S ribosomal protein L4 | 0 | 2 | 0 | 2 |
50S ribosomal protein L22 | 0 | 2 | 0 | 2 |
50S ribosomal protein L5 | 0 | 2 | 0 | 2 |
30S ribosomal protein S21 | 0 | 2 | 0 | 2 |
50S ribosomal protein L25 | 0 | 2 | 0 | 2 |
50S ribosomal protein L36 2 | 0 | 2 | 0 | 2 |
Protein Rev | 0 | 0 | 1 | 1 |
Aminoglycoside 3'-phosphotransferase | 0 | 0 | 0 | 1 |
Tyrosyl-DNA phosphodiesterase 1 | 0 | 2 | 0 | 2 |
Lysine-specific demethylase 4E | 0 | 1 | 0 | 1 |
NADP-dependent malic enzyme, mitochondrial | 0 | 0 | 0 | 1 |
Prolyl 4-hydroxylase | 0 | 1 | 0 | 1 |
Alpha-ketoglutarate-dependent dioxygenase FTO | 0 | 2 | 0 | 2 |
Methyl-accepting chemotaxis protein NahY | 0 | 0 | 2 | 2 |
Thrombopoietin | 2 | 0 | 0 | 2 |
Adenylate cyclase type 1 | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 5 | 0 | 0 | 5 |
serine/threonine-protein kinase mTOR isoform 1 | 5 | 0 | 0 | 5 |
transient receptor potential cation channel subfamily V member 1 | 1 | 0 | 0 | 1 |
Cocaine esterase | 0 | 2 | 0 | 2 |
Transient receptor potential cation channel subfamily V member 1 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 3 | 0 | 3 |
UDP-glucuronosyltransferase 1A9 | 0 | 1 | 0 | 3 |
Voltage-dependent L-type calcium channel subunit alpha-1F | 0 | 5 | 0 | 5 |
Potassium channel subfamily K member 2 | 0 | 1 | 0 | 1 |
Vitamin D-binding protein | 0 | 1 | 0 | 1 |
HLA class I histocompatibility antigen, A alpha chain | 0 | 0 | 1 | 1 |
Integrin beta-1 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2C | 0 | 6 | 0 | 6 |
Beta-2 adrenergic receptor | 0 | 2 | 0 | 2 |
Angiotensin-converting enzyme | 0 | 7 | 0 | 7 |
Integrin alpha-4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 7 | 0 | 7 |
Beta-1 adrenergic receptor | 0 | 3 | 0 | 3 |
D(2) dopamine receptor | 0 | 3 | 0 | 3 |
D(4) dopamine receptor | 0 | 5 | 1 | 8 |
D(1B) dopamine receptor | 0 | 2 | 0 | 3 |
Adenylate cyclase type 3 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A4 | 0 | 0 | 0 | 2 |
Sodium-dependent dopamine transporter | 0 | 3 | 0 | 3 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
Adenosine receptor A1 | 0 | 2 | 0 | 3 |
Beta-3 adrenergic receptor | 0 | 1 | 0 | 1 |
Adenylate cyclase type 2 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 4 | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1D | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 1F | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2B | 0 | 6 | 0 | 6 |
Histamine H1 receptor | 0 | 4 | 1 | 5 |
Sodium-dependent serotonin transporter | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
C-8 sterol isomerase | 0 | 2 | 0 | 2 |
Delta-type opioid receptor | 0 | 2 | 0 | 2 |
Mu-type opioid receptor | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 2C | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 7 | 0 | 2 | 0 | 2 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 2 | 0 | 2 |
Sodium channel protein type 1 subunit alpha | 0 | 3 | 0 | 3 |
Adenylate cyclase type 8 | 0 | 1 | 0 | 1 |
Kappa-type opioid receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 1 | 0 | 1 |
D(1A) dopamine receptor | 4 | 1 | 0 | 5 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
D(3) dopamine receptor | 0 | 1 | 0 | 1 |
Gastrin/cholecystokinin type B receptor | 0 | 1 | 0 | 1 |
AP-2 complex subunit sigma | 0 | 1 | 0 | 1 |
N-acetyltransferase Eis | 0 | 2 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2B | 0 | 1 | 0 | 2 |
Glutamate receptor ionotropic, NMDA 2C | 0 | 1 | 0 | 2 |
Sodium channel protein type 7 subunit alpha | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1D | 0 | 5 | 0 | 5 |
5-hydroxytryptamine receptor 2B | 0 | 2 | 0 | 2 |
Adenylate cyclase type 6 | 0 | 1 | 0 | 1 |
Adenylate cyclase type 5 | 0 | 1 | 0 | 1 |
Voltage-dependent L-type calcium channel subunit alpha-1S | 0 | 5 | 0 | 5 |
Voltage-dependent L-type calcium channel subunit alpha-1C | 0 | 5 | 0 | 5 |
Sodium channel protein type 5 subunit alpha | 0 | 4 | 0 | 4 |
3-beta-hydroxysteroid-Delta(8),Delta(7)-isomerase | 0 | 3 | 1 | 4 |
Calcitonin gene-related peptide type 1 receptor | 0 | 1 | 0 | 1 |
Genome polyprotein | 0 | 2 | 0 | 2 |
Sigma intracellular receptor 2 | 0 | 2 | 0 | 2 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 0 | 2 |
Zinc finger protein 664 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2D | 0 | 1 | 0 | 2 |
Vesicular acetylcholine transporter | 0 | 1 | 0 | 1 |
Transporter | 0 | 2 | 0 | 2 |
Cholecystokinin receptor type A | 0 | 1 | 0 | 1 |
Protease | 0 | 2 | 0 | 2 |
Adenylyl cyclase 7 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 3B | 0 | 1 | 0 | 2 |
D | 0 | 1 | 0 | 1 |
Sodium channel protein type 2 subunit alpha | 0 | 3 | 0 | 3 |
Transient receptor potential cation channel subfamily V member 4 | 0 | 1 | 0 | 1 |
Sodium channel protein type 3 subunit alpha | 0 | 3 | 0 | 3 |
Sigma non-opioid intracellular receptor 1 | 0 | 2 | 1 | 3 |
Glutamate receptor ionotropic, NMDA 3A | 0 | 1 | 0 | 2 |
Sodium channel protein type 11 subunit alpha | 0 | 1 | 0 | 1 |
Sodium channel protein type 8 subunit alpha | 0 | 1 | 0 | 1 |
Transient receptor potential cation channel subfamily V member 2 | 0 | 1 | 0 | 1 |
Sodium channel protein type 10 subunit alpha | 0 | 1 | 0 | 1 |
Chain E, Fibrin beta chain | 0 | 2 | 0 | 2 |
WRN | 1 | 0 | 0 | 1 |
MPI protein | 0 | 1 | 0 | 1 |
Cyclin-dependent kinase 5, regulatory subunit 1 (p35) | 0 | 0 | 0 | 1 |
luciferase | 2 | 0 | 0 | 2 |
pyruvate kinase | 4 | 0 | 0 | 4 |
CDK5 | 0 | 0 | 0 | 1 |
serine-protein kinase ATM isoform a | 2 | 0 | 0 | 2 |
major prion protein preproprotein Prp precursor | 0 | 1 | 0 | 1 |
Tat | 0 | 1 | 0 | 1 |
endoribonuclease toxin MazF | 0 | 0 | 1 | 1 |
Pyruvate kinase PKM | 0 | 1 | 0 | 1 |
Endothelin receptor type B | 3 | 0 | 0 | 3 |
Endothelin-1 receptor | 3 | 0 | 0 | 3 |
phosphoglycerate kinase | 2 | 0 | 0 | 2 |
hypothetical protein CAALFM_CR05890CA | 0 | 0 | 0 | 1 |
H3 histone acetyltransferase | 0 | 0 | 0 | 1 |
Chain A, CARBONIC ANHYDRASE II | 0 | 0 | 1 | 1 |
Chain A, Protein (female-specific Histamine Binding Protein 2) | 0 | 0 | 1 | 1 |
aryl hydrocarbon receptor nuclear translocator | 0 | 0 | 0 | 1 |
transforming acidic coiled-coil-containing protein 3 | 0 | 0 | 0 | 1 |
Macrophage migration inhibitory factor | 0 | 2 | 0 | 2 |
Metabotropic glutamate receptor 5 | 0 | 2 | 1 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Histamine H3 receptor | 0 | 1 | 0 | 1 |
Histamine N-methyltransferase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase-like protein, putative | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Carbonic anhydrase | 0 | 1 | 0 | 3 |
Equilibrative nucleoside transporter 4 | 0 | 0 | 0 | 1 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 2 | 3 |
Histamine H4 receptor | 0 | 1 | 0 | 1 |
Carbonic anhydrase 13 | 0 | 1 | 0 | 2 |
Carboxylic ester hydrolase | 0 | 0 | 0 | 1 |
Histamine H3 receptor | 0 | 2 | 2 | 4 |
signal transducer and activator of transcription 6, interleukin-4 induced | 1 | 0 | 0 | 1 |
DNA repair and recombination protein RAD54-like isoform 1 | 0 | 0 | 0 | 1 |
ras-related protein Rab-9A | 7 | 0 | 0 | 7 |
DNA repair protein RAD52 homolog isoform a | 0 | 0 | 0 | 2 |
Glutamate receptor 1 | 1 | 0 | 0 | 1 |
Glutamate receptor 3 | 1 | 0 | 0 | 1 |
Glutamate receptor 4 | 1 | 0 | 0 | 1 |
DNA-(apurinic or apyrimidinic site) endonuclease | 0 | 1 | 1 | 2 |
Chain A, membrane-associated prostaglandin E synthase-2 | 0 | 1 | 0 | 1 |
Prostaglandin-H2 D-isomerase | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 2 | 0 | 3 |
Prostaglandin G/H synthase 2 | 0 | 2 | 0 | 3 |
3',5'-cyclic-AMP phosphodiesterase | 0 | 2 | 0 | 2 |
Solute carrier organic anion transporter family member 2B1 | 0 | 2 | 0 | 2 |
Cytochrome c oxidase subunit 2 | 0 | 1 | 0 | 1 |
Phospholipase A2, major isoenzyme | 0 | 2 | 0 | 2 |
Albumin | 0 | 2 | 2 | 4 |
Neuronal acetylcholine receptor subunit alpha-4 | 1 | 1 | 0 | 2 |
Interleukin-8 | 0 | 1 | 0 | 1 |
Neuronal acetylcholine receptor subunit beta-2 | 1 | 1 | 0 | 2 |
Aldo-keto reductase family 1 member C4 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 1 | 0 | 1 | 0 | 1 |
Serum paraoxonase/arylesterase 1 | 0 | 3 | 0 | 3 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Caspase-1 | 0 | 1 | 0 | 2 |
Sodium- and chloride-dependent GABA transporter 2 | 0 | 1 | 0 | 1 |
Sodium- and chloride-dependent GABA transporter 3 | 0 | 1 | 0 | 1 |
Multidrug resistance-associated protein 1 | 0 | 1 | 0 | 1 |
Bifunctional epoxide hydrolase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 1 |
Peroxisome proliferator-activated receptor gamma | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member C3 | 0 | 2 | 0 | 2 |
Sodium- and chloride-dependent betaine transporter | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 3 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member C2 | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor | 0 | 2 | 0 | 2 |
Prostaglandin G/H synthase 2 | 0 | 3 | 0 | 3 |
Aldo-keto reductase family 1 member C1 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 2 | 0 | 1 | 0 | 2 |
Uracil nucleotide/cysteinyl leukotriene receptor | 0 | 1 | 0 | 1 |
Rho-associated protein kinase 2 | 0 | 1 | 0 | 1 |
Prostaglandin G/H synthase 1 | 0 | 1 | 0 | 1 |
Nicotinate phosphoribosyltransferase | 0 | 1 | 0 | 1 |
Dehydrogenase/reductase SDR family member 9 | 0 | 1 | 0 | 1 |
Solute carrier organic anion transporter family member 1B3 | 0 | 2 | 0 | 2 |
Cytosolic phospholipase A2 gamma | 0 | 1 | 0 | 1 |
Prostaglandin D2 receptor 2 | 0 | 1 | 1 | 2 |
Solute carrier organic anion transporter family member 1B1 | 0 | 2 | 0 | 2 |
Chymotrypsinogen A | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 0 | 1 | 0 | 1 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
25-hydroxyvitamin D-1 alpha hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
Cytochrome P450 26A1 | 0 | 1 | 0 | 1 |
Camphor 5-monooxygenase | 0 | 0 | 0 | 1 |
Epoxide hydrolase 1 | 0 | 0 | 0 | 1 |
Cytochrome P450 2C11 | 0 | 1 | 0 | 1 |
Steroid 21-hydroxylase | 0 | 1 | 0 | 1 |
Cytochrome P450 2C8 | 0 | 1 | 0 | 1 |
Steroid 17-alpha-hydroxylase/17,20 lyase | 0 | 1 | 0 | 1 |
Cholesterol side-chain cleavage enzyme, mitochondrial | 0 | 1 | 0 | 1 |
Indoleamine 2,3-dioxygenase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2A2 | 0 | 1 | 0 | 1 |
Cytochrome P450 11B1, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
Estrogen receptor | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1A1 | 0 | 1 | 0 | 1 |
Gonadotropin-releasing hormone receptor | 0 | 1 | 1 | 2 |
Type-1 angiotensin II receptor | 0 | 1 | 0 | 1 |
Malate dehydrogenase, cytoplasmic | 0 | 1 | 0 | 1 |
Cytochrome P450 4F2 | 0 | 1 | 0 | 1 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 2 | 0 | 2 |
1,25-dihydroxyvitamin D(3) 24-hydroxylase, mitochondrial | 0 | 1 | 0 | 1 |
Cytochrome P450 7A1 | 0 | 1 | 0 | 1 |
Lanosterol 14-alpha demethylase | 0 | 2 | 0 | 2 |
GTP-binding protein (rab7) | 0 | 0 | 1 | 1 |
ras protein, partial | 0 | 0 | 1 | 1 |
Rac1 protein | 0 | 0 | 1 | 1 |
cell division cycle 42 (GTP binding protein, 25kDa), partial | 0 | 0 | 1 | 1 |
UDP-glucuronosyltransferase 1A3 | 0 | 0 | 0 | 1 |
Caspase-3 | 0 | 1 | 0 | 1 |
Caspase-4 | 0 | 1 | 0 | 1 |
Caspase-5 | 0 | 1 | 0 | 1 |
Caspase-9 | 0 | 1 | 0 | 1 |
Ras-related protein Rab-2A | 0 | 0 | 1 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Alkaline phosphatase, placental type | 0 | 1 | 0 | 1 |
Alkaline phosphatase, tissue-nonspecific isozyme | 0 | 2 | 0 | 2 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
Intestinal-type alkaline phosphatase | 0 | 1 | 0 | 1 |
5'-nucleotidase | 0 | 1 | 0 | 1 |
Phospholipase A-2-activating protein | 0 | 1 | 0 | 1 |
Synaptic vesicle glycoprotein 2A | 0 | 2 | 0 | 2 |
Tyrosine-protein kinase ABL1 | 0 | 3 | 0 | 3 |
Proto-oncogene tyrosine-protein kinase Src | 0 | 3 | 0 | 3 |
Vascular endothelial growth factor receptor 2 | 0 | 2 | 0 | 2 |
T cell receptor, partial | 1 | 0 | 0 | 1 |
luteinizing hormone receptor | 1 | 0 | 0 | 1 |
integrase, partial | 0 | 1 | 0 | 1 |
lens epithelium-derived growth factor p75 | 0 | 1 | 0 | 1 |
Caspase 6, apoptosis-related cysteine peptidase | 0 | 0 | 0 | 1 |
TSHR protein | 2 | 0 | 0 | 2 |
Apoptotic peptidase activating factor 1 | 0 | 1 | 0 | 1 |
isocitrate dehydrogenase 1, partial | 1 | 0 | 0 | 1 |
neutrophil cytosol factor 1 | 0 | 1 | 0 | 1 |
caspase-9 isoform alpha precursor | 0 | 1 | 0 | 1 |
caspase-3 isoform a preproprotein | 0 | 1 | 0 | 1 |
protein AF-9 isoform a | 0 | 0 | 0 | 1 |
replicative DNA helicase | 0 | 0 | 0 | 1 |
recombinase A | 0 | 0 | 1 | 1 |
POsterior Segregation | 0 | 0 | 1 | 1 |
Glutathione reductase | 0 | 1 | 0 | 1 |
Glutathione reductase, mitochondrial | 0 | 2 | 0 | 3 |
Glycoprotein hormones alpha chain | 1 | 0 | 0 | 1 |
Dihydrolipoyl dehydrogenase, mitochondrial | 0 | 1 | 0 | 2 |
Cruzipain | 0 | 1 | 0 | 1 |
Dihydrolipoyl dehydrogenase | 0 | 1 | 0 | 2 |
Zinc finger protein mex-5 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3E | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 0 | 1 | 1 |
Myeloperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3A | 0 | 2 | 0 | 2 |
5-hydroxytryptamine receptor 3A | 0 | 0 | 1 | 1 |
6-phosphogluconate dehydrogenase, decarboxylating | 0 | 1 | 0 | 1 |
Lactoperoxidase | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 4 | 0 | 1 | 0 | 2 |
5-hydroxytryptamine receptor 3D | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3C | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 3B | 0 | 2 | 0 | 2 |
Thioredoxin reductase | 0 | 1 | 0 | 1 |
Flavodoxin | 0 | 0 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA topoisomerase 4 subunit A | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily E member 1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit A | 0 | 1 | 0 | 1 |
Potassium voltage-gated channel subfamily KQT member 1 | 0 | 1 | 0 | 1 |
DNA gyrase subunit B | 0 | 1 | 0 | 2 |
DNA gyrase subunit A | 0 | 1 | 0 | 2 |
Sialidase-4 | 0 | 1 | 0 | 1 |
Sialidase-1 | 0 | 1 | 0 | 1 |
Sialidase-3 | 0 | 1 | 0 | 1 |
NPC intracellular cholesterol transporter 1 precursor | 5 | 0 | 0 | 5 |
pyruvate kinase PKM isoform b | 1 | 0 | 0 | 1 |
Aurora kinase A | 0 | 2 | 0 | 2 |
3-phosphoinositide-dependent protein kinase 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase JAK2 | 0 | 1 | 0 | 1 |
Tyrosine-protein kinase Lyn | 0 | 1 | 0 | 1 |
Ornithine decarboxylase | 1 | 0 | 0 | 1 |
Platelet-derived growth factor receptor beta | 0 | 1 | 0 | 1 |
Mast/stem cell growth factor receptor Kit | 0 | 1 | 0 | 1 |
Fibroblast growth factor receptor 1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase B-raf | 0 | 1 | 0 | 1 |
Protein kinase C alpha type | 0 | 3 | 1 | 4 |
RAC-alpha serine/threonine-protein kinase | 0 | 1 | 0 | 1 |
Signal transducer and activator of transcription 3 | 0 | 3 | 0 | 3 |
Mitogen-activated protein kinase 8 | 0 | 1 | 0 | 1 |
Angiopoietin-1 receptor | 0 | 1 | 0 | 1 |
Anoctamin-1 | 0 | 2 | 0 | 2 |
Rap guanine nucleotide exchange factor 4 | 1 | 0 | 0 | 1 |
Pyruvate-flavodoxin oxidoreductase | 0 | 1 | 0 | 1 |
Snake venom metalloproteinase BaP1 | 0 | 1 | 0 | 1 |
NAD(+) hydrolase SARM1 | 0 | 2 | 0 | 2 |
Hematopoietic prostaglandin D synthase | 0 | 1 | 0 | 1 |
C-terminal-binding protein 1 | 1 | 0 | 0 | 1 |
DNA polymerase beta | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase non-receptor type 1 | 0 | 1 | 0 | 1 |
Tyrosine-protein phosphatase 1 | 0 | 1 | 0 | 1 |
G-protein coupled receptor 35 | 0 | 1 | 1 | 2 |
Protein arginine N-methyltransferase 5 | 0 | 1 | 0 | 1 |
Protein tyrosine phosphatase type IVA 3 | 0 | 1 | 0 | 1 |
Coagulation factor X | 0 | 1 | 0 | 1 |
Plasminogen | 0 | 1 | 0 | 1 |
Urokinase-type plasminogen activator | 0 | 1 | 0 | 1 |
Protein S100-B | 0 | 1 | 1 | 2 |
Glyceraldehyde-3-phosphate dehydrogenase | 0 | 1 | 0 | 1 |
Protein S100-B | 0 | 0 | 1 | 1 |
Trypsin-1 | 0 | 1 | 0 | 1 |
Acrosin | 0 | 1 | 0 | 1 |
Amiloride-sensitive amine oxidase [copper-containing] | 0 | 1 | 0 | 1 |
Diamine acetyltransferase 1 | 0 | 1 | 0 | 1 |
Cytochrome P450 2C19 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 1 | 0 | 1 | 0 | 1 |
Glutamate receptor ionotropic, NMDA 2A | 0 | 1 | 0 | 1 |
Protein tyrosine phosphatase type IVA 2 | 0 | 1 | 0 | 1 |
Nuclear receptor subfamily 3 group C member 3 | 0 | 6 | 0 | 6 |
Protein tyrosine phosphatase type IVA 1 | 0 | 1 | 0 | 1 |
Aurora kinase B | 0 | 1 | 0 | 1 |
Protein arginine N-methyltransferase 1 | 0 | 1 | 0 | 1 |
Suppressor of tumorigenicity 14 protein | 0 | 1 | 0 | 1 |
beta-2 adrenergic receptor | 1 | 0 | 0 | 1 |
mu-type opioid receptor isoform MOR-1 | 0 | 0 | 1 | 1 |
5-hydroxytryptamine receptor 2A | 0 | 0 | 1 | 1 |
Gamma-aminobutyric acid | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-6 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit delta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-2 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-1 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit beta-3 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-5 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit pi | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit alpha-4 | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit theta | 0 | 1 | 0 | 1 |
Gamma-aminobutyric acid receptor subunit gamma-1 | 0 | 1 | 0 | 1 |
4-hydroxyphenylpyruvate dioxygenase | 0 | 1 | 0 | 1 |
karyopherin alpha 2 (RAG cohort 1, importin alpha 1), isoform CRA_b | 0 | 0 | 1 | 1 |
luciferase | 0 | 0 | 0 | 1 |
Fatty acid-binding protein, liver | 0 | 1 | 0 | 1 |
Glucocorticoid receptor | 0 | 0 | 1 | 1 |
Glutamine synthetase | 0 | 0 | 1 | 1 |
Nociceptin receptor | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 5 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
Trace amine-associated receptor 1 | 0 | 0 | 1 | 1 |
heat shock protein HSP 90-alpha isoform 2 | 0 | 0 | 0 | 1 |
heat shock protein 90, putative | 0 | 0 | 0 | 1 |
N | 0 | 1 | 0 | 1 |
NPYLR7B | 0 | 0 | 1 | 1 |
cystic fibrosis transmembrane conductance regulator | 0 | 1 | 0 | 1 |
Major prion protein | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit alpha | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit omega | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta' | 0 | 1 | 0 | 1 |
DNA-directed RNA polymerase subunit beta | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
Phospholipase A2, membrane associated | 0 | 1 | 0 | 1 |
Acidic phospholipase A2 2 | 0 | 1 | 0 | 1 |
Trypanothione reductase | 0 | 2 | 0 | 2 |
Aldehyde oxidase 1 | 0 | 1 | 0 | 1 |
Cyclic GMP-AMP synthase | 0 | 1 | 0 | 1 |
2,3-bisphosphoglycerate-independent phosphoglycerate mutase | 1 | 0 | 0 | 1 |
Glycine receptor subunit alpha-1 | 0 | 0 | 1 | 1 |
3-hydroxy-3-methylglutaryl-coenzyme A reductase | 0 | 1 | 0 | 1 |
D(2) dopamine receptor | 0 | 1 | 0 | 1 |
5-hydroxytryptamine receptor 1A | 0 | 1 | 0 | 1 |
Transporter | 0 | 1 | 0 | 1 |
C-X-C chemokine receptor type 5 isoform 1 | 0 | 1 | 0 | 1 |
ubiquitin-conjugating enzyme E2 N | 0 | 2 | 0 | 2 |
C-C chemokine receptor type 6 | 0 | 1 | 0 | 1 |
apelin receptor | 0 | 1 | 0 | 1 |
bcl-2-related protein A1 | 0 | 1 | 0 | 1 |
streptokinase A precursor | 0 | 0 | 2 | 2 |
Endoglycoceramidase II | 0 | 0 | 0 | 1 |
Protein kinase C alpha type | 0 | 2 | 0 | 2 |
Estrogen receptor | 0 | 0 | 2 | 3 |
Protein kinase C delta type | 0 | 2 | 0 | 2 |
Protein kinase C epsilon type | 0 | 2 | 0 | 2 |
Protein kinase C zeta type | 0 | 2 | 0 | 2 |
cAMP-dependent protein kinase catalytic subunit alpha | 0 | 1 | 0 | 1 |
Protein kinase C gamma type | 0 | 2 | 0 | 2 |
Protein kinase C beta type | 0 | 2 | 0 | 2 |
Estrogen receptor beta | 0 | 0 | 2 | 3 |
Protein kinase C eta type | 0 | 2 | 0 | 2 |
Sphingosine kinase 2 | 0 | 1 | 0 | 1 |
Sphingosine kinase 1 | 0 | 1 | 0 | 1 |
Protein kinase C theta type | 0 | 2 | 0 | 2 |
Sphingosine 1-phosphate receptor 2 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 4 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 1 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 3 | 0 | 1 | 1 | 2 |
Sphingosine 1-phosphate receptor 5 | 0 | 1 | 1 | 2 |
Enoyl-[acyl-carrier-protein] reductase [NADH] | 0 | 0 | 0 | 1 |
Substance-P receptor | 0 | 2 | 0 | 2 |
Neuromedin-K receptor | 0 | 0 | 1 | 1 |
Substance-K receptor | 0 | 1 | 1 | 2 |
Substance-P receptor | 0 | 4 | 1 | 5 |
Neuromedin-K receptor | 0 | 1 | 1 | 2 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Substance-K receptor | 0 | 1 | 0 | 1 |
Growth hormone secretagogue receptor type 1 | 0 | 0 | 1 | 1 |
Mas-related G-protein coupled receptor member X2 | 0 | 0 | 1 | 1 |
Carbonic anhydrase | 0 | 0 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 1 | 2 |
Carbonic anhydrase 5A, mitochondrial | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Beta-carbonic anhydrase 1 | 0 | 1 | 0 | 1 |
Carbonic anhydrase 2 | 0 | 1 | 0 | 1 |
Carbonic anhydrase, alpha family | 0 | 1 | 0 | 1 |
Carbonic anhydrase | 0 | 1 | 0 | 1 |
Delta carbonic anhydrase | 0 | 1 | 0 | 1 |
Protein argonaute-2 | 0 | 0 | 1 | 1 |
Chain A, CES1 protein | 0 | 1 | 0 | 1 |
DNA polymerase III, partial | 1 | 0 | 0 | 1 |
interferon gamma precursor | 0 | 0 | 0 | 1 |
Serine/threonine-protein kinase D3 | 0 | 1 | 1 | 2 |
Lysosomal acid glucosylceramidase | 0 | 0 | 1 | 1 |
Protein kinase C gamma type | 0 | 2 | 1 | 3 |
Protein kinase C beta type | 0 | 2 | 1 | 3 |
Steroid hormone receptor ERR1 | 0 | 1 | 0 | 1 |
Transcriptional activator protein LuxR | 0 | 1 | 0 | 1 |
Beta-3 adrenergic receptor | 0 | 2 | 0 | 2 |
Protein kinase C eta type | 0 | 1 | 1 | 2 |
B2 bradykinin receptor | 0 | 2 | 0 | 2 |
Melanocortin receptor 4 | 0 | 2 | 0 | 2 |
Melanocortin receptor 5 | 0 | 2 | 0 | 2 |
Protein kinase C iota type | 0 | 1 | 1 | 2 |
Melanocortin receptor 3 | 0 | 2 | 0 | 2 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Protein kinase C epsilon type | 0 | 2 | 1 | 3 |
Protein kinase C theta type | 0 | 1 | 1 | 2 |
Protein kinase C zeta type | 0 | 1 | 1 | 2 |
Protein kinase C delta type | 0 | 2 | 1 | 3 |
Serine/threonine-protein phosphatase 2B catalytic subunit alpha isoform | 0 | 1 | 0 | 1 |
Platelet-activating factor acetylhydrolase | 0 | 1 | 0 | 1 |
Phospholipase D1 | 0 | 1 | 0 | 1 |
Serine/threonine-protein kinase D1 | 0 | 1 | 1 | 2 |
Emopamil-binding protein-like | 0 | 1 | 0 | 1 |
7-dehydrocholesterol reductase | 0 | 1 | 1 | 2 |
Luciferin 4-monooxygenase | 0 | 0 | 1 | 1 |
Ras guanyl-releasing protein 3 | 0 | 0 | 1 | 1 |
Chain A, Methionine aminopeptidase | 0 | 1 | 0 | 1 |
Methionine aminopeptidase 2 | 0 | 1 | 0 | 1 |
Methionine aminopeptidase 1 | 0 | 1 | 1 | 2 |
Peptidyl-prolyl cis-trans isomerase FKBP1A | 0 | 0 | 1 | 1 |
Reverse transcriptase/RNaseH | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine kinase, cytosolic | 0 | 2 | 0 | 4 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidine phosphorylase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase, cytosolic | 0 | 0 | 0 | 2 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidylate kinase | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 1 | 0 | 2 |
Sterol O-acyltransferase 1 | 0 | 1 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Thymidine kinase | 0 | 0 | 0 | 1 |
Olfactory receptor 51E2 | 0 | 0 | 1 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
UDP-glucuronosyltransferase 1-6 | 0 | 0 | 0 | 1 |
Liver carboxylesterase 1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member A1 | 0 | 1 | 0 | 1 |
Aldo-keto reductase family 1 member B7 | 0 | 1 | 0 | 1 |
NAD-dependent protein deacylase sirtuin-5, mitochondrial | 0 | 1 | 0 | 1 |
[prepared from compound, protein, and bioassay information from National Library of Medicine (NLM), extracted Dec-2023] |